Cantitate/Preț
Produs

Pharmaceutical Computer Systems Validation: Quality Assurance, Risk Management and Regulatory Compliance, Volume 1: Drugs and the Pharmaceutical Sciences

Editat de Guy Wingate
en Limba Engleză Hardback – 15 iun 2026
Computerised systems play a fundamental role in the development, manufacture and supply of medical treatments. This is the third and thoroughly updated edition of the best-selling book dealing with validation, compliance and software in the pharmaceutical, healthcare and medical device industries. The first volume provides a comprehensive walk-through of lifecycle and development methodologies bringing together technological advances, latest regulatory requirements, inspection findings, and compliance strategies. New chapters have been added on agile development methodologies, data integrity, artificial intelligence and machine learning. The second volume comprises an extensive set of refreshed case studies spanning laboratory, manufacturing and supply chain systems with new contributions on databases, spreadsheets, LIMS, blockchain, mobile devices, AI-enabled systems, big data and digital twins authored by various industry experts.
Key Features
  • Covers organizational responsibilities, project lifecycle, operational compliance, risk management, data integrity, practical trouble shooting, handling regulatory inspections, metrics and the opportunity for performance improvement.
  • Includes 20 new and updated case studies by industry experts, demonstrating how these computer system validation principles are put into practice.
  • Discusses industry regulations and guidance including current thinking of US FDA on computer software assurance, the latest guidance from US FDA/EU/MHRA on data integrity and newly published ISPE GAMP 5 Guide (Second Edition).
  • Focuses on regulatory requirements covering GCPs, GLPs, GMPs and GDPs – complete with observations from inspections by US FDA and other regulators
  • Includes new material dealing with the latest advancements concerning data integrity, machine-learning and artificial intelligence, data-lakes, cloud computing services, mobile devices, and IT tools.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 40190 lei  22-36 zile +2436 lei  6-12 zile
  CRC Press – 14 oct 2024 40190 lei  22-36 zile +2436 lei  6-12 zile
Hardback (3) 136732 lei  43-57 zile
  CRC Press – 23 feb 2010 136732 lei  43-57 zile
  CRC Press – 15 iun 2026 122611 lei  Precomandă
  CRC Press – 15 iun 2026 122611 lei  Precomandă

Din seria Drugs and the Pharmaceutical Sciences

Preț: 122611 lei

Preț vechi: 156659 lei
-22% Precomandă

Puncte Express: 1839

Preț estimativ în valută:
21707 25276$ 18857£

Carte nepublicată încă

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781032981086
ISBN-10: 1032981083
Pagini: 440
Ilustrații: 246
Dimensiuni: 178 x 254 mm
Ediția:3. Auflage
Editura: CRC Press
Colecția CRC Press
Seria Drugs and the Pharmaceutical Sciences


Public țintă

Postgraduate, Professional Practice & Development, Professional Reference, and Undergraduate Advanced

Cuprins

Foreword. Preface. About The Editor. Abbreviations. Chapter 1 Introduction. Chapter 2 Organization and Management. Chapter 3 Lifecycle Methodologies & Supporting Processes. Chapter 4 Prospective Verification and Validation. Chapter 5 Project Initiation and Compliance Determination. Chapter 6 Requirements Capture and Supplier (Vendor) Selection. Chapter 7 Design and Development. Chapter 8 Coding, Configuration, and Build. Chapter 9 Development Testing. Chapter 10 User Qualification and Authorization to Use. Chapter 11 Operation and Maintenance. Chapter 12 Phaseout and Withdrawal. Chapter 13 Data Integrity. Chapter 14 Regulated Electronic Records and Electronic Signatures. Chapter 15 Artificial Intelligence & Machine Learning. Chapter 16 Regulatory Inspections. Chapter 17 Compliance Strategies. Chapter 18 Capabilities, Measures, and Performance. Chapter 19 Practical Troubleshooting. Chapter 20 Concluding Remarks. Glossary. Index

Notă biografică

Guy Wingate, PhD, was Vice-President of Compliance at GlaxoSmithKline until his recent retirement. A well-known speaker on computer validation, Dr Wingate has over 30 years’ experience in the pharmaceutical industry. He has been a visiting lecturer at the University of Manchester’s M.Sc. Pharmaceutical Engineering Advanced Training program and Dublin Institute of Technology’s accredited M.Sc. Validation Science program. Dr Wingate is an active member of the ISPE and was chair of the GAMP Council for 10 years which is responsible for the internationally recognized suite of GAMP Guides on computer compliance. Dr Wingate’s extensive list of published work includes the books Validating Corporate Computer Systems and previous editions of this book Pharmaceutical Computer Systems Validation.

Descriere

This new edition deals with validation, compliance and software in the pharmaceutical, healthcare and medical device industries. The first volume provides a walk-through of lifecycle and development methodologies, and the second volume comprises a set of refreshed case studies spanning laboratory, manufacturing and supply chain systems.